---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-023963"
form_type: "8-K"
ticker: null
cik: "0001169987"
company_name: "HTG MOLECULAR DIAGNOSTICS, INC"
filed_at: "2023-05-24T23:59:59+00:00"
generated_at: "2026-06-14T15:41:51.860724+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nasdaq notifies HTG Molecular of delisting risk for equity below $2.5M

## Summary
- Nasdaq notice on May 18, 2023: stockholders' equity fell below $2.5M as of March 31, 2023.
- Company must submit a compliance plan by July 3, 2023 under Nasdaq Rule 5550(b).
- If plan is accepted, Nasdaq may grant up to 180-day extension for evidence of compliance.
- No assurance of regaining compliance; delisting remains a possibility.

## SEC filing metadata
- accession: 0000950170-23-023963
- form_type: 8-K
- cik: 0001169987
- company_name: HTG MOLECULAR DIAGNOSTICS, INC
- filed_at: 2023-05-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1169987/000095017023023963/0000950170-23-023963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1169987/000095017023023963/htgm-20230518.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-023963
- JSON: https://secwatch.observer/filing/0000950170-23-023963.json
- Plain text: https://secwatch.observer/filing/0000950170-23-023963.txt

## Key facts
- Listing & Compliance Notices
  HTG MOLECULAR DIAGNOSTICS, INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)
  source text: May 18, 2023, HTG Molecular Diagnostics, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that, as a result of the Company’s stockholders’ equity falling below $2.5 million, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, the Company does not satisfy one of The Nasdaq Capital Market continued listing requirement set forth in Nasdaq Stock Market Rule 5550(b) (the “Rule”). Pursuant to the Notice and Nasdaq rules, the Company has 45 calendar days, or until July 3, 2023, to submit a plan to regain compl
  evidence_url: https://www.sec.gov/Archives/edgar/data/1169987/000095017023023963/0000950170-23-023963-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.